Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis.

Miller AE, O'Connor P, Wolinsky JS, Confavreux C, Kappos L, Olsson TP, Truffinet P, Wang L, D'Castro L, Comi G, Freedman MS, Teriflunomide Multiple Sclerosis Trial Group

Open source

DOI: 10.1177/1352458512450354
Published: 2012 Nov
Container: Multiple sclerosis (Houndmills, Basingstoke, England)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/1352458512450354,
  title = {Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis.},
  author = {Miller AE and O'Connor P and Wolinsky JS and Confavreux C and Kappos L and Olsson TP and Truffinet P and Wang L and D'Castro L and Comi G and Freedman MS and Teriflunomide Multiple Sclerosis Trial Group},
  year = {2012},
  journal = {Multiple sclerosis (Houndmills, Basingstoke, England)},
  doi = {10.1177/1352458512450354},
  url = {https://doi.org/10.1177/1352458512450354}
}

RIS

TY  - JOUR
TI  - Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis.
AU  - Miller AE
AU  - O'Connor P
AU  - Wolinsky JS
AU  - Confavreux C
AU  - Kappos L
AU  - Olsson TP
AU  - Truffinet P
AU  - Wang L
AU  - D'Castro L
AU  - Comi G
AU  - Freedman MS
AU  - Teriflunomide Multiple Sclerosis Trial Group
PY  - 2012
JO  - Multiple sclerosis (Houndmills, Basingstoke, England)
DO  - 10.1177/1352458512450354
UR  - https://doi.org/10.1177/1352458512450354
ER  -

APA

AE, M., P, O., JS, W., C, C., L, K., TP, O., P, T., L, W., L, D., G, C., MS, F., & Group, T. M. S. T. (2012). Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis.. Multiple sclerosis (Houndmills, Basingstoke, England). https://doi.org/10.1177/1352458512450354

Source records

pubmed · retrieved 2026-09-27T16:47:48.890Z